When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GMAB - FDA OKs subcutaneous version of J&J's Darzalex
Genmab A/S
The FDA approves a subcutaneous formulation of Johnson & Johnson's (JNJ-1.9%) multiple myeloma med Darzalex (daratumumab). Originally, the CD38-directed cytolytic antibody was administered via intravenous infusion.
More news on: Johnson & Johnson, Halozyme Therapeutics, Inc., Genmab A/S, Healthcare stocks news,